Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the efficacy, safety, and tolerability of TERN-601 in adults with overweight or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight or Obesity

Drugs mentioned

• TERN-601

Snippet

Sponsor: Terns, Inc. | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED